LSU Biomedical Research Center: Studying Treatments and Therapy for Dementia Patients
June 22, 2023
June 22, 2023
BATON ROUGE, Louisiana, June 22 (TNSres) -- The Louisiana State University's Pennington Biomedical Research Center issued the following news release:
Pennington Biomedical is one of 15 sites in the country that is part of a National Institutes of Health, or NIH, funded clinical trial focused on Delta-9-tetrahydrocannabinol, or THC. The purpose of the trial is to determine if THC decreases agitation in hospice eligible dementia patients.
THC is currently a Schedule1 . . .
Pennington Biomedical is one of 15 sites in the country that is part of a National Institutes of Health, or NIH, funded clinical trial focused on Delta-9-tetrahydrocannabinol, or THC. The purpose of the trial is to determine if THC decreases agitation in hospice eligible dementia patients.
THC is currently a Schedule1 . . .